Zerumbone from Zingiber zerumbet inhibits innate and adaptive immune responses in Balb/C mice

Ibrahim Jantan, Md Areeful Haque, Menaga Ilangkovan, Laiba Arshad

Research output: Contribution to journalArticle

Abstract

Zerumbone exhibited various biological properties including in vitro immunosuppressive effects. However, its modulatory activity on the immune responses in experimental animal model is largely unknown. This investigation was conducted to explore the effects of daily treatment of zerumbone (25, 50, and 100 mg/kg) isolated from Zingiber zerumbet rhizomes for 14 days on various cellular and humoral immune responses in Balb/C mice. For measurement of adaptive immunity, sheep red blood cells (sRBC) were used to immunize the mice on day 0 and orally fed with similar doses of zerumbone for 14 days. The effects of zerumbone on phagocytosis, nitric oxide (NO) release, myeloperoxidase (MPO) activity, proliferation of T and B cells, lymphocyte phenotyping, cytokines release in serum by activated T cells, delayed type hypersensitivity (DTH) and immunoglobulins production (IgG and IgM) were investigated. Zerumbone downregulated the engulfment of E. coli by peritoneal macrophages and the release of NO and MPO in a concentration-dependent manner. Zerumbone showed significant and concentration-dependent suppression of T and B lymphocytes proliferation and inhibition of the Th1 and Th2 cytokines release. At higher concentrations of zerumbone, the % expression of CD4+ and CD8+ in splenocytes was significantly inhibited. Zerumbone also concentration-dependently demonstrated strong suppression on sRBC-triggered swelling of mice paw in DTH. Substantial suppression of anti-sRBC immunoglobulins antibody titer was noted in immunized and zerumbone-treated mice in a concentration-dependent manner. The potent suppressive effects of zerumbone on the immune responses suggest that zerumbone can be a potential candidate for development of immunosuppressive agent.

Original languageEnglish
Pages (from-to)552-559
Number of pages8
JournalInternational Immunopharmacology
Volume73
DOIs
Publication statusPublished - 1 Aug 2019
Externally publishedYes

Fingerprint

Adaptive Immunity
Innate Immunity
Sheep
Erythrocytes
Delayed Hypersensitivity
Immunosuppressive Agents
T-Lymphocytes
Peroxidase
Immunoglobulins
Nitric Oxide
zerumbone
B-Lymphocytes
Cytokines
Immunophenotyping
Rhizome
Peritoneal Macrophages
Humoral Immunity
Phagocytosis
Cellular Immunity
Immunoglobulin M

Keywords

  • Adaptive immunity
  • Immunoglobulins
  • Immunosuppressant
  • Innate immunity
  • T and B cells proliferation
  • Zerumbone

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Pharmacology

Cite this

Zerumbone from Zingiber zerumbet inhibits innate and adaptive immune responses in Balb/C mice. / Jantan, Ibrahim; Haque, Md Areeful; Ilangkovan, Menaga; Arshad, Laiba.

In: International Immunopharmacology, Vol. 73, 01.08.2019, p. 552-559.

Research output: Contribution to journalArticle

Jantan, Ibrahim ; Haque, Md Areeful ; Ilangkovan, Menaga ; Arshad, Laiba. / Zerumbone from Zingiber zerumbet inhibits innate and adaptive immune responses in Balb/C mice. In: International Immunopharmacology. 2019 ; Vol. 73. pp. 552-559.
@article{6664ff1747994f57a234bca4cef145ad,
title = "Zerumbone from Zingiber zerumbet inhibits innate and adaptive immune responses in Balb/C mice",
abstract = "Zerumbone exhibited various biological properties including in vitro immunosuppressive effects. However, its modulatory activity on the immune responses in experimental animal model is largely unknown. This investigation was conducted to explore the effects of daily treatment of zerumbone (25, 50, and 100 mg/kg) isolated from Zingiber zerumbet rhizomes for 14 days on various cellular and humoral immune responses in Balb/C mice. For measurement of adaptive immunity, sheep red blood cells (sRBC) were used to immunize the mice on day 0 and orally fed with similar doses of zerumbone for 14 days. The effects of zerumbone on phagocytosis, nitric oxide (NO) release, myeloperoxidase (MPO) activity, proliferation of T and B cells, lymphocyte phenotyping, cytokines release in serum by activated T cells, delayed type hypersensitivity (DTH) and immunoglobulins production (IgG and IgM) were investigated. Zerumbone downregulated the engulfment of E. coli by peritoneal macrophages and the release of NO and MPO in a concentration-dependent manner. Zerumbone showed significant and concentration-dependent suppression of T and B lymphocytes proliferation and inhibition of the Th1 and Th2 cytokines release. At higher concentrations of zerumbone, the {\%} expression of CD4+ and CD8+ in splenocytes was significantly inhibited. Zerumbone also concentration-dependently demonstrated strong suppression on sRBC-triggered swelling of mice paw in DTH. Substantial suppression of anti-sRBC immunoglobulins antibody titer was noted in immunized and zerumbone-treated mice in a concentration-dependent manner. The potent suppressive effects of zerumbone on the immune responses suggest that zerumbone can be a potential candidate for development of immunosuppressive agent.",
keywords = "Adaptive immunity, Immunoglobulins, Immunosuppressant, Innate immunity, T and B cells proliferation, Zerumbone",
author = "Ibrahim Jantan and Haque, {Md Areeful} and Menaga Ilangkovan and Laiba Arshad",
year = "2019",
month = "8",
day = "1",
doi = "10.1016/j.intimp.2019.05.035",
language = "English",
volume = "73",
pages = "552--559",
journal = "International Immunopharmacology",
issn = "1567-5769",
publisher = "Elsevier",

}

TY - JOUR

T1 - Zerumbone from Zingiber zerumbet inhibits innate and adaptive immune responses in Balb/C mice

AU - Jantan, Ibrahim

AU - Haque, Md Areeful

AU - Ilangkovan, Menaga

AU - Arshad, Laiba

PY - 2019/8/1

Y1 - 2019/8/1

N2 - Zerumbone exhibited various biological properties including in vitro immunosuppressive effects. However, its modulatory activity on the immune responses in experimental animal model is largely unknown. This investigation was conducted to explore the effects of daily treatment of zerumbone (25, 50, and 100 mg/kg) isolated from Zingiber zerumbet rhizomes for 14 days on various cellular and humoral immune responses in Balb/C mice. For measurement of adaptive immunity, sheep red blood cells (sRBC) were used to immunize the mice on day 0 and orally fed with similar doses of zerumbone for 14 days. The effects of zerumbone on phagocytosis, nitric oxide (NO) release, myeloperoxidase (MPO) activity, proliferation of T and B cells, lymphocyte phenotyping, cytokines release in serum by activated T cells, delayed type hypersensitivity (DTH) and immunoglobulins production (IgG and IgM) were investigated. Zerumbone downregulated the engulfment of E. coli by peritoneal macrophages and the release of NO and MPO in a concentration-dependent manner. Zerumbone showed significant and concentration-dependent suppression of T and B lymphocytes proliferation and inhibition of the Th1 and Th2 cytokines release. At higher concentrations of zerumbone, the % expression of CD4+ and CD8+ in splenocytes was significantly inhibited. Zerumbone also concentration-dependently demonstrated strong suppression on sRBC-triggered swelling of mice paw in DTH. Substantial suppression of anti-sRBC immunoglobulins antibody titer was noted in immunized and zerumbone-treated mice in a concentration-dependent manner. The potent suppressive effects of zerumbone on the immune responses suggest that zerumbone can be a potential candidate for development of immunosuppressive agent.

AB - Zerumbone exhibited various biological properties including in vitro immunosuppressive effects. However, its modulatory activity on the immune responses in experimental animal model is largely unknown. This investigation was conducted to explore the effects of daily treatment of zerumbone (25, 50, and 100 mg/kg) isolated from Zingiber zerumbet rhizomes for 14 days on various cellular and humoral immune responses in Balb/C mice. For measurement of adaptive immunity, sheep red blood cells (sRBC) were used to immunize the mice on day 0 and orally fed with similar doses of zerumbone for 14 days. The effects of zerumbone on phagocytosis, nitric oxide (NO) release, myeloperoxidase (MPO) activity, proliferation of T and B cells, lymphocyte phenotyping, cytokines release in serum by activated T cells, delayed type hypersensitivity (DTH) and immunoglobulins production (IgG and IgM) were investigated. Zerumbone downregulated the engulfment of E. coli by peritoneal macrophages and the release of NO and MPO in a concentration-dependent manner. Zerumbone showed significant and concentration-dependent suppression of T and B lymphocytes proliferation and inhibition of the Th1 and Th2 cytokines release. At higher concentrations of zerumbone, the % expression of CD4+ and CD8+ in splenocytes was significantly inhibited. Zerumbone also concentration-dependently demonstrated strong suppression on sRBC-triggered swelling of mice paw in DTH. Substantial suppression of anti-sRBC immunoglobulins antibody titer was noted in immunized and zerumbone-treated mice in a concentration-dependent manner. The potent suppressive effects of zerumbone on the immune responses suggest that zerumbone can be a potential candidate for development of immunosuppressive agent.

KW - Adaptive immunity

KW - Immunoglobulins

KW - Immunosuppressant

KW - Innate immunity

KW - T and B cells proliferation

KW - Zerumbone

UR - http://www.scopus.com/inward/record.url?scp=85066815095&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066815095&partnerID=8YFLogxK

U2 - 10.1016/j.intimp.2019.05.035

DO - 10.1016/j.intimp.2019.05.035

M3 - Article

AN - SCOPUS:85066815095

VL - 73

SP - 552

EP - 559

JO - International Immunopharmacology

JF - International Immunopharmacology

SN - 1567-5769

ER -